Alternative spliced transcripts as cancer markers

Disease Markers

Volumn 17, Issue 2, 2001, Pages 67-75

  Caballero, Otavia L ^a,b   De Souza, Sandro J ^a,b   Brentani, Ricardo R ^a   Simpson, Andrew J G ^a,b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN CD44; PROTEIN WT1; TUMOR MARKER; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER; CANCER GENETICS; CARCINOGENESIS; CELL LINE; DISEASE COURSE; EUKARYOTE; EXON; GENE EXPRESSION; GENE NUMBER; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN GENETICS; INTRON; NEPHROBLASTOMA; PRIORITY JOURNAL;

EID: 0034794132     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/184856     Document Type: Article

References (37)

1. Alternative splicing of pre-mRNA: Developmental consequences and mechanisms of regulation
2. Alternative pre-mRNA splicing: The logic of combinatorial control
3. Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
4. Alternative splicing: Increasing diversity in the proteomic world
5. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity
6. Determinants of SR protein specificity
7. ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome
8. Alternative splicing of human genes: More the rule than the exception?
9. Initial sequencing and analysis of the human genome
10. Alternative splicing of fibroblast growth factor receptors in human prostate cancer
11. Expression profiles of BRCA1 splice variants in asynchronous and inG1/S synchronized tumor cell lines
12. WT1 splicing alterations in Wilms' tumors
13. Splice variant expression of CD44 in patients with breast and ovarian cancer
14. Alternatively spliced MDM2 transcripts in human breast cancer in relation to tumor necrosis and lymph node involvement
15. CD44: Structure, function, and association with the malignant process
16. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
17. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells
18. The normal structure and function of CD44 and its role in neoplasia
19. Adhesion proteins in the biology of breast cancer: Contribution of CD44
20. CD44 in inflammation and metastasis
21. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor
22. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells
23. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer
24. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma
25. Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast
26. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
27. Wilms tumor and the wt1 gene
28. Alternative splicing and genomic structure of the Wilms tumor gene WT1
29. RNA editing in the Wilms' tumor susceptibility gene WT1
30. non-AUG translational initiation event generates novel WT1 isoforms
31. Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties
32. The Wilms' tumor suppressor WT1: Approaches to gene function
33. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript
34. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing
35. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function
36. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis
37. Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer